Kidney TransplantationOrgan TransplantationTransplantsGraft RejectionGraft SurvivalImmunosuppressive AgentsLiver TransplantationTransplantation, HomologousTissue DonorsTransplantationTissue and Organ ProcurementHeart TransplantationKidneyLiving DonorsLung TransplantationPancreas TransplantationKidney Failure, ChronicTransplantation ImmunologyBone Marrow TransplantationCadaverImmunosuppressionImmunocompromised HostTacrolimusWaiting ListsPostoperative ComplicationsTreatment OutcomeHematopoietic Stem Cell TransplantationRetrospective StudiesTime FactorsDelayed Graft FunctionMycophenolic AcidCyclosporineBlood Group IncompatibilityKidney DiseasesCytomegalovirus InfectionsTransplantation, AutologousHistocompatibility TestingTransplantation ToleranceTransplantation ConditioningBrain DeathLymphoproliferative DisordersFollow-Up StudiesStem Cell TransplantationRisk FactorsHeart-Lung TransplantationGanciclovirOpportunistic InfectionsFacial TransplantationIslets of Langerhans TransplantationDonor SelectionABO Blood-Group SystemCytomegalovirusDeathSurvival RateKidney Function TestsHLA AntigensIncidenceRenal DialysisTransplantation, IsogeneicCreatinineIsoantibodiesCalcineurinCell TransplantationTransplantation ChimeraHistocompatibilityGraft vs Host DiseaseProspective StudiesGlomerular Filtration RateLiver FailureCohort StudiesKidney TubulesSurvival AnalysisAntilymphocyte SerumSkin NeoplasmsTransplantation, HeterotopicOrgan PreservationBiopsyDirected Tissue DonationAntiviral AgentsMycosesPlasmapheresisFetal Tissue TransplantationRecurrencePrognosisSirolimusEyebrowsRenal InsufficiencyCryptococcosisRegistriesPostoperative PeriodCord Blood Stem Cell TransplantationAcute Kidney InjuryFatal OutcomeKeratosis, ActinicCold IschemiaUnited StatesZygomycosisBiological MarkersDrug Therapy, CombinationEpstein-Barr Virus Infections